| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/04/1994 | US5276022 Combination of estrogen and progestin |
| 01/04/1994 | US5276020 Anti-virals |
| 01/04/1994 | US5276019 Inhibitors for replication of retroviruses and for the expression of oncogene products |
| 01/04/1994 | US5276018 Composition comprising amino acids and methods for decreasing muscle breakdown |
| 01/04/1994 | US5276014 Human growth factor |
| 01/04/1994 | US5276013 Conjugates of biologically stable polyfunctional molecules and polynucleotides for treating systemic lupus erythematosus |
| 01/04/1994 | US5275824 Therapeutic compositions with controlled release of medicaments supported on crosslinked polymers and coated with polymer films, and their preparation process |
| 01/04/1994 | US5275823 Histamine H2 receptor antagonists containing cimetidine |
| 01/04/1994 | US5275822 Dry, uniform, free-flowing granular carbohydrate agglomerate; hydrocarbon, mineral or silicone oils containing silica |
| 01/04/1994 | US5275821 Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules |
| 01/04/1994 | US5275816 Cephalosporin derivatives |
| 01/04/1994 | US5275805 Inhibitors of plaque in mouths with mixtures of salicylanilide and nonionic surfactants |
| 01/04/1994 | US5275801 13,17-propionic acid and propionic acid derivative substituted porphyrin complex compounds, process for their production and pharmaceutical agents containing them |
| 01/04/1994 | CA2099556A1 2-amino-n-¬¬¬4-(aminocarbonyl)pyrimidin-2-yl|amino|alkyl| pyrimidine-4-carboxamide derivatives, preparation thereof and therapeutical application thereof |
| 01/04/1994 | CA2097167A1 Thienothiazine derivatives, process for their preparation and their use |
| 01/04/1994 | CA2092617A1 Bioreductive agents |
| 01/04/1994 | CA1325811C Norbornane derivatives, process for their preparation, and cosmetic and pharmaceutical compositions containing them |
| 01/04/1994 | CA1325810C Cyanoacetamido-derivatives having a fungicidal activity |
| 01/04/1994 | CA1325809C Phenylene furyl, and thienyl leukotriene b_ analogues |
| 01/04/1994 | CA1325807C Tetracyclic antidepressants |
| 01/04/1994 | CA1325804C Thienotricycles for the treatment of bronchial diseases |
| 01/03/1994 | CA2099630A1 Heterocyclyl-phenoxyalkyl-piperidinylpyridazines as antiviral agents |
| 01/03/1994 | CA2099295A1 Thiazolylvinylphenyl derivatives |
| 01/03/1994 | CA2098241A1 Tetrazolyl-(phenoxy and phenoxyalkyl)-piperidinylpyridazines as antiviral agents |
| 01/02/1994 | CA2099712A1 Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates |
| 01/02/1994 | CA2099447A1 Angiotensin ii receptor antagonists for the treatment and prophylaxis of coronary heart disease |
| 01/02/1994 | CA2099445A1 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 01/02/1994 | CA2099425A1 Angiotensin ii receptor antagonists for the treatment of disturbances in cardiac rhythm |
| 01/02/1994 | CA2095487A1 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists |
| 12/31/1993 | CA2099453A1 N-benzoylamino acid derivatives, pharmaceutical compositions containing them and process for preparing same |
| 12/31/1993 | CA2076944A1 Ajoene as an agent for inhibiting symptoms and growth of aids virus and changes at the cellular level |
| 12/30/1993 | CA2099233A1 Morpholine and thiomorpholine tachykinin receptor antagonists |
| 12/29/1993 | EP0576396A1 Amidine compounds and new amidine compounds and their use for the treatment of disorders of calcium metabolism |
| 12/29/1993 | EP0576357A1 Pyrazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/29/1993 | EP0576350A1 Branched alkylamino thiozole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 12/29/1993 | EP0576349A1 Indolizine derivatives, process of preparation and use for the preparation of aminoalkyloxybenzenesulfonylindolizine compounds with pharmaceutical activity |
| 12/29/1993 | EP0576251A1 Substituted 1,2,4-triazine-3,5-dione derivatives and drug compositions containing them, particularly for coccidiosis treatment |
| 12/29/1993 | EP0576230A1 2'-deoxy-2', 2'-difluoro(4-substituted pyrimidine) nucleosides having antiviral and anti-cancer activity and intermediates |
| 12/29/1993 | EP0576227A2 2'-Deoxy-2',2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates |
| 12/29/1993 | EP0575974A1 Use of 24,25-dihydroxyvitamin D3 for the manufacture of a medicament for the treatment of rickets |
| 12/29/1993 | EP0575954A1 Aminoalkylcarbamic esters of eseroline suitable for use as cholinesterase acitivity inhibitors and relative preparation process |
| 12/29/1993 | EP0575923A1 Triazole Derivatives |
| 12/29/1993 | EP0575890A1 Fumaric acid salts of quinoline derivatives to overcome MDR in cancer treatment |
| 12/29/1993 | EP0575846A2 Food and feedstuff containing lipase inhibitors |
| 12/29/1993 | EP0575844A2 Hydroxamic acid derivatives and pharmaceutical compositions thereof |
| 12/29/1993 | EP0575841A1 Composition containing dibucaine hydrochloride, a salicylate, calcium bromide and an antiphlopstic steroid for the treatment of pain |
| 12/29/1993 | EP0575782A1 Phenyl-1,2,5-oxadiazole-carbonamide-2-oxides for the treatment of cardiovascular disorders, in particular erectile dysfunction |
| 12/29/1993 | EP0575754A1 Pyridyl-1,2,5-oxadiazol-2-oxide-carbonamides for the treatment of NO-dependent disfunctions like angina pectoris and erection disorders |
| 12/29/1993 | EP0575749A2 Use of potassium-channel activators for the manufacture of a medicament for the treatment of gastrointertinal ulcers |
| 12/29/1993 | EP0575614A1 Thiazole derivatives |
| 12/29/1993 | EP0575613A1 Pharmaceutical preparation of antistress, stress-preventive and nootropic action |
| 12/29/1993 | EP0575572A1 Stable salts of (+)-(1s,2r)-2- n-(2-hydroxylamino-2-oxoethyl)-n-methyl-amino]carbonyl]cyclohexane-1-carboxylic acid, process for their preparation and pharmaceutical compositions containing them |
| 12/29/1993 | EP0575557A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 12/29/1993 | EP0575556A1 Palytoxin-related prodrugs and a method for their administration |
| 12/29/1993 | EP0575526A1 6,9 BIS(SUBSTITUTED-AMINO)BENZO g]ISOQUINOLINE-5,10-DIONES |
| 12/29/1993 | EP0575524A1 Method and products for treating the eye |
| 12/29/1993 | EP0575500A1 Hiv protease inhibitors |
| 12/29/1993 | EP0575496A1 Cosmetic or pharmaceutical, especially dermatological, composition,containing oxyacanthine, in particular for stimulating hair growth or retarding hair loss. |
| 12/29/1993 | EP0575494A1 Leukotriene antagonists |
| 12/29/1993 | EP0575490A1 GnRH ANALOGS |
| 12/29/1993 | EP0575484A1 Method for promoting tissue repair and regeneration |
| 12/29/1993 | EP0575482A1 Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 12/29/1993 | EP0575464A1 Modified factor vii |
| 12/29/1993 | EP0575454A1 Use of cucurbitin for the preparation of a cosmetic or pharmaceutical, particularly dermatological, antiallergenic composition and method involving application thereof. |
| 12/29/1993 | EP0575439A1 Granules and veterinary compositions comprising a water-soluble complex of flumequine |
| 12/29/1993 | EP0575430A1 Preparation of a medicament for the treatment of addiction to drugs and substances of abuse |
| 12/29/1993 | EP0575425A1 USE OF OXAZOLO- 2,3-a]ISOINDOLE AND IMIDAZO 2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO 2,3-a]ISOINDOLE DERIVATIVES. |
| 12/29/1993 | EP0575375A1 Antibacterial condensed carbapenemes |
| 12/29/1993 | EP0575362A1 TETRAHYDROTHIENO(2,3-c)PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL APPLICATION |
| 12/29/1993 | EP0575361A1 New 1-aryl-4-piperazinyl-cyclohexanecarboxylic acid nitriles, their production and their use. |
| 12/29/1993 | EP0516729B1 N-phenyl n-alkoxycarbonylalkyl glycinamides, preparation method and drugs containing them |
| 12/29/1993 | EP0470176B1 Substituted 3-amino chromans |
| 12/29/1993 | EP0433275B1 Composition based on heparin micropolysaccharides, active when administered orally |
| 12/29/1993 | EP0418248B1 Transdermal multipolymer drug delivery system |
| 12/29/1993 | EP0314690B1 Sigma brain receptor ligands and their use |
| 12/29/1993 | CN1079967A Method for producing carbohydrates |
| 12/29/1993 | CN1079966A Heterocyclic compounds, their productin and use |
| 12/29/1993 | CN1079964A Oxazolidinone antimicrobials containing substituted diazine moieties |
| 12/29/1993 | CN1079954A Novel compound |
| 12/29/1993 | CN1079908A Histamine derivatives and methods for their use as immunomodulators |
| 12/29/1993 | CN1079900A 1,6-fructose diphosphate sodium salt oral liquor |
| 12/29/1993 | CN1079899A Compound surface anaesthesia |
| 12/29/1993 | CN1079898A Oxaspiro |2,5¨ octane derivative |
| 12/29/1993 | CN1079897A Drug for treatment of the injured skull |
| 12/29/1993 | CN1079896A Topical aromatic releasing compositions |
| 12/29/1993 | CN1023322C Carboxyalkenamidocephalosporins compound preparation |
| 12/29/1993 | CN1023320C Process for preparing a benzoxazinnorifamycim derivative |
| 12/29/1993 | CN1023318C Process for preparing 1-hydroxyalkyl-5-nitro imidazoles |
| 12/29/1993 | CN1023293C Controlling-release preparation |
| 12/28/1993 | US5274118 Reduction and hydrogenolysis of a diastereomeric butyramide |
| 12/28/1993 | US5274116 1-aminoacetamidopyrroles and 1-aminoacetamido-2-(substituted)pyrroles and related compounds |
| 12/28/1993 | US5274111 Trifluoromethyl substituted 1H-pyrazoles and derivatives thereof |
| 12/28/1993 | US5274104 N-substituted heterocyclic derivatives useful in the treatment of cardiovascular disorders |
| 12/28/1993 | US5274098 Amidinophenylalanine derivatives, process for their preparation, their use and compositions containing them |
| 12/28/1993 | US5274094 Production of heterobicyclic containing benzene sulfonamides |
| 12/28/1993 | US5274001 Orthostatic lavage solutions |
| 12/28/1993 | US5273999 Carboxylic acid leukotriene B4 antagonists |
| 12/28/1993 | US5273995 [R-(R*R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl-3-phenyl-4-[(phenylamino) carbonyl]- 1H-pyrrole-1-heptanoic acid, its lactone form and salts thereof |
| 12/28/1993 | US5273993 Compounds having one or more aminosulfonyloxy radicals useful as pharmaceuticals |
| 12/28/1993 | US5273992 Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ |